What Is GIVE?
Generic Initiative for Value and Efficiency or GIVE is an initiative by the Food and Drug Association to bring in more generic drug products to the markets so that they can make cheaper drugs more wide spread to the public.
Its purpose is to get higher numbers of applicants and give priority drugs because there are fewer generics available.
In order to make this happen, the FDA needs to streamline the regulatory and approve the process in order to keep getting more applications and regulate pharmaceutical companies and more efficiently keep higher standards.
It is important because the increasing volume of applications and the expansion of the association and the workload that has picked up over the years due to the rate of the advanced medical science.
An interview with GIVE and their Direction of the Office of Generic Drugs Mr. Buehler, RPH, said that this was going to be achieved.
Q: How will the goals of GIVE happen?
A: GIVE will work by combining our offices different efforts into one harmonized activity to implement process improvements through the entire program. The initiative is to review oriented programs that are focused on three main ideas:
- Mobilizing staff effort to increase review productivity.
- Optimizing the capacity and capability of all assets within OGD and leveraging wherever possible resources from FDA components.
- Using every possible place to recruit and hire reviewers for the critical care needs of patients.
Generic Drugs
The Regulations Of Generic Drugs
How Pharmaceutical Companies Stop Generics Being Made?
Is There A Difference Between Generic And The Name Brand Drug?
Why Is Generic Drugs Less Expensive?
Generic Drugs
... humanitarian reasons. One other problem is to ensure that the prices remain low so that the developing countries can afford them. This will require a market that is big enough to attract large amounts of competition that will help to lower the prices. There are some claims that the large Pharmaceutical ...
... to do the same job but just a little bit different so that they are not affected by the existing patents. Companies may also produce generic types of a patented drug in countries that are not covered by a patent. Some companies can apply for a five-year extension to their patent to make up for the time ...
... will release the same amount of active ingredient to the blood stream over the same amount of time. So this means that they will work exactly the same way. The regulation and safety of the generic drugs is just as tough as the name brand goes through. Generic drugs are made in exactly the same way as ...
... generic drugs are made by the company that developed the original drug. Are generic drugs made in the same standard facilities as the name brand ones? Yes al facilities have to meet the FDA standards. Why do all the brand name and generic drugs look different? The trademark laws do not allow the generic ...
Why Is Generic Drugs Less Expensive?
... are replaced in order to make this money back before the patent runs out. They do not need to lower the price of the produce because they do not have any competition due to the fact that they are the only ones allowed to make the drug. Usually there are lower costs in making and testing the drug for manufacture ...